Patent ID: 7507732

Claim:
A compound of Formula (I) wherein; m is 1 or 2; n is 0 or 1; L is —CHR 0a —, where R 0a is hydrogen or (C 1 -C 4 )alkyl; R 2 is hydrogen or methyl; R 3 is selected from the group consisting of H, Cl, Br, F, CH 3 and CN; R 1 is (a) a group of Formula (IA) where (i) p, r and s are each independently 0 or 1, and R 1a , R 1b and R 1c are each independently selected from the group consisting of F, Cl, Br l, cyano, —CH 2 —CN, —NH 2 , —OH, (C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxy, (C 1 -C 4 )alkylthio, fluoro-substituted (C 1 -C 4 )alkyl, fluoro-substituted (C 1 -C 4 )alkoxy, fluoro-substituted (C 1 -C 4 )alkylthio, —NH—C(O)—(C 1 -C 4 )alkyl, —C(O)—(C 1 -C 4 )alkyl, —C(O)—O(C 1 -C 4 )alkyl, —C(O)—NH 2 , —C(O)—NH(C 1 -C 4 )alkyl, a 3- to 6-membered carbocyclic ring, and phenyl substituted with F, Cl, Br or I; or (ii) p and r are each 0, s is 1, and R 1c is independently selected from the group consisting of phenyl, phenoxy optionally substituted with F, Cl, Br, or I; benzyl, benzyloxy, —NH(C 1 -C 4 )alkyl, —N[(C 1 -C 4 )alkyl] 2 , —CH 2 —NH(C 1 -C 4 )alkyl, —CH 2 —N[(C 1 -C 4 )alkyl] 2 , —NH(phenyl), —NH(5- to 6-membered heteroaryl containing 1 to 3 hetero atoms independently selected from O, N, and S, which is optionally substituted with 1 to 3 halo groups), —N(CH 3 )—SO 2 (C 1 -C 4 )alkyl, —NH—SO 2 (C 1 -C 4 )alkyl, —NHC(O)NH 2 , —C(O)—N[(C 1 -C 4 )alkyl] 2 , —C(O)-(5- to 6-membered heterocycle containing 1 to 3 hetero atoms independently selected from O, N, and S), —C(O)—NH(5- to 6-membered heterocycle containing 1 to 3 hetero atoms independently selected from O, N, and S), —C(O)-(5- to 6-membered carbocycle), —CH 2 —C(O)—O(C 1 -C 4 )alkyl, a 3- to 6-membered heterocyclic ring containing 1 to 3 heteroatoms independently selected from O, N or S, and a 5- to 6-membered heteroaryl containing 1 to 3 heteroaroms independently selected from O, N or S which is optionally substituted with one to three substituents independently selected from a F, Cl, Br, I, and CF 3 ; (b) a 5- to 6-membered heteroaryl containing 1 to 3 heteroatoms independently selected from O, S or N, where said heteroaryl is optionally fused to a 5- to 6- membered carbocyclic ring or a 6-membered aromatic ring and said heteroaryl is optionally substituted with 1 to 2 substituents independently selected from the group consisting of cyano, F, Cl, Br, I, (C 1 -C 4 )alkyl, (C 1 -C 4 )alkoxy, and —C(O)—O(C 1 -C 4 )alkyl; or a pharmaceutically acceptable salt thereof.